Published in Cell on February 05, 2015
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design. Immunity (2015) 1.66
Can immunological principles and cross-disciplinary science illuminate the path to vaccines for HIV and other global health challenges? Philos Trans R Soc Lond B Biol Sci (2015) 0.95
Antibody-Based Strategies to Prevent and Treat Influenza. Front Immunol (2015) 0.88
Strategies to guide the antibody affinity maturation process. Curr Opin Virol (2015) 0.87
Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising. Proc Natl Acad Sci U S A (2015) 0.83
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants. Viruses (2015) 0.82
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination. Proc Natl Acad Sci U S A (2016) 0.81
Trade-offs in antibody repertoires to complex antigens. Philos Trans R Soc Lond B Biol Sci (2015) 0.80
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting. PLoS Pathog (2017) 0.78
Approaches to the induction of HIV broadly neutralizing antibodies. Curr Opin HIV AIDS (2016) 0.77
Anti-RAINBOW dye-specific antibodies as universal tools for the visualization of prestained protein molecular weight markers in Western blot analysis. Sci Rep (2016) 0.77
The challenges of modelling antibody repertoire dynamics in HIV infection. Philos Trans R Soc Lond B Biol Sci (2015) 0.76
Host-Pathogen Coevolution and the Emergence of Broadly Neutralizing Antibodies in Chronic Infections. PLoS Genet (2016) 0.76
The evolution within us. Philos Trans R Soc Lond B Biol Sci (2015) 0.76
Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies. Immunol Rev (2017) 0.76
The B Cell Response to Foot-and-Mouth Disease Virus in Cattle following Sequential Vaccination with Multiple Serotypes. J Virol (2017) 0.75
Optimal Sequential Immunization Can Focus Antibody Responses against Diversity Loss and Distraction. PLoS Comput Biol (2017) 0.75
Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogens. Proc Natl Acad Sci U S A (2016) 0.75
DNA-peptide complexes: Regulation of interferon production. Nat Mater (2015) 0.75
A Population Dynamics Model for Clonal Diversity in a Germinal Center. Front Microbiol (2017) 0.75
What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise. Cold Spring Harb Perspect Biol (2017) 0.75
Antibody neutralization and escape by HIV-1. Nature (2003) 21.48
The antigenic structure of the HIV gp120 envelope glycoprotein. Nature (1998) 12.44
VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE. Biochemistry (1964) 11.48
Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature (2011) 11.07
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science (2010) 10.69
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature (2002) 9.62
Germinal centers. Annu Rev Immunol (2012) 6.26
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J Virol (2009) 5.91
Maturation of the immune response in germinal centers. Cell (1991) 5.68
Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science (2013) 5.53
Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell (2010) 5.49
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature (2013) 5.35
In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp Med (1991) 4.98
Imaging of germinal center selection events during affinity maturation. Science (2006) 4.86
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science (2013) 4.61
Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev (1987) 4.16
Structural insights into the evolution of an antibody combining site. Science (1997) 3.92
Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. J Virol (1992) 3.79
Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature (2014) 3.50
HIV-1 neutralizing antibodies: understanding nature's pathways. Immunol Rev (2013) 3.30
Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity (1998) 3.27
A Blueprint for HIV Vaccine Discovery. Cell Host Microbe (2012) 3.27
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell (2013) 3.04
Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell (2014) 2.36
Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. Cell (2014) 2.27
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Nat Rev Immunol (2013) 2.22
Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity (2013) 2.13
Functional anatomy of germinal centers. Am J Anat (1984) 2.00
Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope. Structure (2010) 1.91
Stepwise intraclonal maturation of antibody affinity through somatic hypermutation. Proc Natl Acad Sci U S A (1988) 1.87
T follicular helper cell dynamics in germinal centers. Science (2013) 1.80
Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design. J Virol (2003) 1.78
Germinal centers develop oligoclonally. Eur J Immunol (1987) 1.77
Codon bias targets mutation. Nature (1995) 1.69
The effect of antigen dose and time after immunization on the amount and affinity of anti-hapten antibody. J Immunol (1968) 1.61
The germinal center: a crucible for lymphocyte selection. Semin Immunol (1996) 1.56
Comparing antigenicity and immunogenicity of engineered gp120. J Virol (2005) 1.50
Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat Biotechnol (2011) 1.47
Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant. PLoS One (2011) 1.41
Sequence space localization in the immune system response to vaccination and disease. Phys Rev Lett (2003) 1.39
Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodies. J Virol (2011) 1.33
An analysis of B cell selection mechanisms in germinal centers. Math Med Biol (2006) 1.32
Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts. J Immunol (1997) 1.31
Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation. Front Immunol (2014) 1.19
Somatic hypermutation in B cells: an optimal control treatment. J Theor Biol (1993) 1.14
Clone: a Monte-Carlo computer simulation of B cell clonal expansion, somatic mutation, and antigen-driven selection. Curr Top Microbiol Immunol (1998) 1.07
A spatial model of germinal center reactions: cellular adhesion based sorting of B cells results in efficient affinity maturation. J Theor Biol (2003) 0.98
Somatic mutation of immunoglobulin V genes in vitro. Science (1996) 0.97
A mathematical model for the germinal center morphology and affinity maturation. J Theor Biol (2002) 0.96
Optimality of mutation and selection in germinal centers. PLoS Comput Biol (2010) 0.93
Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially. Vaccine (2012) 0.89
Germinal centers. Immunol Rev (2012) 0.87
Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogens. Proc Natl Acad Sci U S A (2016) 0.75